Claremont BioSolutions Awarded $3M Phase II SBIR NIH Grant

Claremont BioSolutions announces the award of a $3M Phase II SBIR NIH grant to further develop a sample preparation and detection cartridge for Clostridium difficile.

(PRWeb July 16, 2012)

Read the full story at

Comments are closed.

Get email updates

Enter your email address to subscribe to this blog and receive notifications of new posts by email.